Advanced wound care products are used when the standard wound care treatment fails. Treatment in advanced wound care involves interventions therapies and products, such as collagen products, antimicrobial dressings, foam dressings, gauze, hydrocolloids, film dressings, hydrogels, composites, and alginate dressings, among others.
The market has been segmented on the basis of type, application, method, end user, and geography. Geographically, the North America advanced wound care market contributed 34.4%market share in 2014. The European market was valued at USD 3.2 billion in 2014, and is expected to grow at a CAGR of 6.8% from 2015 to 2020. In terms of high growth potential, the U.K. advanced wound care market is an open market, expected to witness growth at the fastest rate from 2015 to 2020.
The global advanced wound care market is expected to grow due to the rising aging population, growing incidences of diabetes, and technological advancements. However, the high cost of advanced wound care products act as a major restraining factor.
Detailed market share analysis of the major players in the global Advanced Wound Care Market is covered in this report. The major companies in this market include Acelity L.P., Inc. (U.S.), Smith and Nephew Plc. (U.K), Integra Lifesciences Corporation (U.S.), M枚lnlycke Health Care (Sweden), ConvaTec, Inc. (U.S.), Coloplast Corp. (Denmark), Organogenesis Inc. (U.S.), Medline Industries, Inc. (U.S.), MPM Medical, Inc. (RBC Life Sciences, Inc.) (U.S.). These companies have adopted various strategies, such as merger & acquisition and partnership, among others, to achieve growth in the global anesthesia monitoring devices market.
